World's Best Scientists 2026 revealed!
Taisuke Tomita

Taisuke Tomita

D-Index & Metrics

Biology and Biochemistry

D-Index
72
Citations
23949
World Ranking
6177
National Ranking
398

Overview

Taisuke Tomita is affiliated with the University of Tokyo in Japan and has made contributions primarily in the fields of Medicine, Biochemistry, Genetics and Molecular Biology, and Neuroscience. Their work spans several subfields including Neurology, Physiology, Molecular Biology, Cell Biology, and Cellular and Molecular Neuroscience.

The scientist's research focuses on topics related to neurodegenerative diseases and neurological mechanisms. Major themes in their work include:

  • Alzheimer's disease research and treatments
  • Neuroinflammation and Neurodegeneration Mechanisms
  • Parkinson's Disease Mechanisms and Treatments
  • Cellular transport and secretion
  • Cholinesterase and Neurodegenerative Diseases
  • Dementia and Cognitive Impairment Research
  • Prion Diseases and Protein Misfolding

Their frequent collaborators include Yukiko Hori, Sho Takatori, Youhei Sohma, Motomu Kanai, and Shigeo Murayama.

Taisuke Tomita has published regularly in venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Alzheimer's & Dementia
  • The FASEB Journal
  • FEBS Open Bio
  • Brain

Some of their recent notable papers include:

  • "Structures of α-synuclein filaments from multiple system atrophy," 2020, Nature
  • "Seeded assembly in vitro does not replicate the structures of α-synuclein filaments from multiple system atrophy," 2021, FEBS Open Bio
  • "Mouse Models of Alzheimer's Disease," 2022, Frontiers in Molecular Neuroscience
  • "Catalytic photooxygenation degrades brain Aβ in vivo," 2021, Science Advances
  • "Structures of α-synuclein filaments from multiple system atrophy," 2020, bioRxiv (Cold Spring Harbor Laboratory)

Best Publications

  • APP processing and synaptic function.

    Flavio Kamenetz;Taisuke Tomita;Helen Hsieh;Helen Hsieh;Guy Seabrook

  • Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies.

    M. Baba;S. Nakajo;P.-H. Tu;T. Tomita

  • High performance plasma amyloid-β biomarkers for Alzheimer’s disease

    Akinori Nakamura;Naoki Kaneko;Victor L Villemagne;Takashi Kato

  • AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss.

    Helen Hsieh;Jannic Boehm;Chihiro Sato;Takeshi Iwatsubo

  • The role of presenilin cofactors in the gamma-secretase complex.

    Nobumasa Takasugi;Taisuke Tomita;Ikuo Hayashi;Makiko Tsuruoka

  • Glial cytoplasmic inclusions in white matter oligodendrocytes of multiple system atrophy brains contain insoluble α‐synuclein

    Pang-hsien Tu;James E. Galvin;James E. Galvin;Minami Baba;Benoit Giasson

  • Structures of α-synuclein filaments from multiple system atrophy

    Manuel Schweighauser;Yang Shi;Airi Tarutani;Airi Tarutani;Fuyuki Kametani

  • Mechanism of Ca2+ disruption in Alzheimer's disease by presenilin regulation of InsP3 receptor channel gating.

    King-Ho Cheung;Diana Shineman;Marioly Müller;César Cárdenas

  • The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue

    Taisuke Tomita;Kei Maruyama;Takaomi C. Saido;Hideaki Kume

  • Effects of PS1 Deficiency on Membrane Protein Trafficking in Neurons

    Satoshi Naruse;Gopal Thinakaran;Jin Jun Luo;John W. Kusiak

  • A loss of function mutation of presenilin-2 interferes with amyloid beta-peptide production and notch signaling.

    Harald Steiner;Karen Duff;Anja Capell;Helmut Romig

  • Neprilysin degrades both amyloid beta peptides 1-40 and 1-42 most rapidly and efficiently among thiorphan- and phosphoramidon-sensitive endopeptidases.

    Keiro Shirotani;Satoshi Tsubuki;Nobuhisa Iwata;Yoshie Takaki

  • Sedation and Anesthesia Mediated by Distinct GABAA Receptor Isoforms

    David S. Reynolds;Thomas W. Rosahl;Jennifer Cirone;Gillian F. O'Meara

  • Presenilins mediate a dual intramembranous γ‐secretase cleavage of Notch‐1

    Masayasu Okochi;Harald Steiner;Akio Fukumori;Hisashi Tanii

  • High performance plasma amyloid-beta biomarkers for Alzheimer's disease

    Akinori Nakamura;Naoki Kaneko;Victor L Villemagne;Takashi Kato

  • A presenilin dimer at the core of the gamma-secretase enzyme: insights from parallel analysis of Notch 1 and APP proteolysis.

    Eric H. Schroeter;Ma. Xenia G. Ilagan;Anne L. Brunkan;Silva Hecimovic

  • Sulindac Sulfide Is a Noncompetitive γ-Secretase Inhibitor That Preferentially Reduces Aβ42 Generation

    Yasuko Takahashi;Ikuo Hayashi;Yusuke Tominari;Kentaro Rikimaru

  • Activity-Dependent Proteolytic Cleavage of Neuroligin-1

    Kunimichi Suzuki;Yukari Hayashi;Soichiro Nakahara;Hiroshi Kumazaki

  • BACE1 activity is modulated by cell-associated sphingosine-1-phosphate

    Nobumasa Takasugi;Tomoki Sasaki;Kunimichi Suzuki;Satoko Osawa

  • Amyloid precursor proteins inhibit heme oxygenase activity and augment neurotoxicity in Alzheimer's disease.

    Masaaki Takahashi;Sylvain Doré;Christopher D. Ferris;Taisuke Tomita

Frequent Co-Authors

Takeshi Iwatsubo
Takeshi Iwatsubo University of Tokyo
Tohru Fukuyama
Tohru Fukuyama Nagoya University
Takaomi C. Saido
Takaomi C. Saido RIKEN Center for Brain Science
Tatsuhiko Kodama
Tatsuhiko Kodama University of Tokyo
Takao Hamakubo
Takao Hamakubo Nippon Medical School
Haruhiko Fuwa
Haruhiko Fuwa Chuo University
Raphael Kopan
Raphael Kopan Cincinnati Children's Hospital Medical Center
Gopal Thinakaran
Gopal Thinakaran University of Chicago
Kunihiko Obata
Kunihiko Obata The Graduate University for Advanced Studies, SOKENDAI
Shoichi Ishiura
Shoichi Ishiura University of Tokyo

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Taisuke Tomita

Trending Scientists